An update on population pharmacokinetic analyses of vancomycin, part II: in pediatric patients

A Aljutayli, I El-Haffaf, A Marsot, F Nekka - Clinical pharmacokinetics, 2022 - Springer
Vancomycin is widely used in pediatric patients, however, large inter-and intraindividual
variability are observed in vancomycin pharmacokinetics, affecting proper therapeutic …

Population pharmacokinetic models of vancomycin in paediatric patients: a systematic review

E Chung, J Sen, P Patel, W Seto - Clinical Pharmacokinetics, 2021 - Springer
Background Vancomycin is commonly used to treat gram-positive bacterial infections in the
paediatric population, but dosing can be challenging. Population pharmacokinetic (popPK) …

AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatrics

SCJ Jorgensen, D Dersch-Mills… - Journal of …, 2021 - academic.oup.com
The revised vancomycin guidelines recommend implementing AUC24-based therapeutic
drug monitoring (TDM) using Bayesian methods in both adults and paediatrics. The …

Should Therapeutic Drug Monitoring Based on the Vancomycin Area Under the Concentration-Time Curve Be Standard for Serious Methicillin-Resistant …

SCJ Jorgensen, B Spellberg, AF Shorr… - Clinical Infectious …, 2021 - academic.oup.com
In this counterpoint we critically appraise the evidence supporting therapeutic drug
monitoring based on the vancomycin 24-hour area under the concentration-time curve …

A moving target—vancomycin therapeutic monitoring

AN Burns, JL Goldman - Journal of the Pediatric Infectious …, 2020 - academic.oup.com
Therapeutic drug monitoring (TDM) has been a common practice to optimize efficacy and
safety of vancomycin. While vancomycin trough-only TDM has widely been integrated into …

Assessment of vancomycin pharmacokinetics and dose regimen optimisation in preterm neonates

M Mulubwa, HA Griesel, P Mugabo, R Dippenaar… - Drugs in R&D, 2020 - Springer
Background The pharmacokinetics of vancomycin, a drug used for the treatment of
methicillin-resistant Staphylococcus aureus (MRSA), varies between paediatric and adult …

Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program

R Velarde-Salcedo, LF Pérez-González… - European Journal of …, 2023 - Springer
Antibiotics are among the most utilized drugs in pediatrics. Nonetheless, there is a lack in
pharmacokinetics information for this population, and dosing criteria may vary between …

Heaping the Pelion of Vancomycin on the Ossa of Methicillin-resistant Staphylococcus aureus: Back to Basics in Clinical Care and Guidelines

WF Wright, SCJ Jorgensen… - Clinical Infectious …, 2021 - academic.oup.com
In Greek mythology, the Titans piled Mount Pelion and Mount Ossa upon Olympus to scale
the dwellings of the Gods but were overwhelmed by Zeus.“Heaping Pelion upon Ossa” thus …

[HTML][HTML] Evaluation of vancomycin individualized model-based dosing approach in neonates

M Abouelkheir, A Almohaizeie, A Almutairi… - Pediatrics & …, 2023 - Elsevier
Background Vancomycin is commonly used to treat methicillin-resistant staphylococcal
infections in neonates. Consensus on its ideal dosing in neonates has not been achieved …

Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus …

R Yoo, H So, E Seo, M Kim, J Lee - PLoS One, 2021 - journals.plos.org
Optimal vancomycin exposure is important to minimize treatment failure of methicillin-
resistant Staphylococcus aureus (MRSA) bacteremia. We aimed to analyze the impact of …